SPECTRUM Nicotine Research Cigarettes
PreclinicalSmall molecule
SPECTRUM Nicotine Research Cigarettes is one of 18 small molecule programs targeting Relapse. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
17
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
17 competitors in Relapse
#DrugCompanyPhaseTrials
1Camptosar
PfizerPhase 3
Zepzelca
Jazz PharmaceuticalsPhase 3
Fludara
SanofiPhase 2
Epkinly
GenmabPhase 2
Venclexta
AbbViePhase 2
Calquence
AstraZenecaPhase 2
Imbruvica
PPharmacyclics LLC.
Phase 2
Chantix
PPrism Pharmaceuticals
Phase 2
BRIUMVI
TTG Therapeutics, Inc.
Phase 2
Ukoniq
TTG Therapeutics, Inc.
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMaggie M Sweitzer, PhD